Clinical Trial Update: Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating an unspecified human monoclonal antibody for mycosis fungoides and Sézary syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Unspecified human monoclonal antibody

Snippet

Sponsor: Emergent Product Development Seattle LLC | Conditions: Mycosis Fungoides, Sezary Syndrome | Phase 3 | Status: TERMINATED